SeaBridge Investment Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
NIM
AAM
MC
FHA
1CP
SeaBridge Investment Advisors's HQL Position: Q4 2020 in Review
SeaBridge Investment Advisors sold out of abrdn Life Sciences Investors (HQL) in Q4 2020, closing a stake of 956 shares — an estimated $17K sold.
SeaBridge Investment Advisors first reported a position in HQL in Q2 2013 and held it in 30 quarters. The position peaked at $27K in Q2 2015. 66 funds tracked by Wall St. Rank hold HQL as of Q4 2020.
- SeaBridge Investment Advisors reported no remaining abrdn Life Sciences Investors position as of Q4 2020 after selling out during the quarter.
- SeaBridge Investment Advisors sold 956 abrdn Life Sciences Investors shares in Q4 2020, an estimated $17K.
- SeaBridge Investment Advisors first reported a position in abrdn Life Sciences Investors in Q2 2013 and held it in 30 quarters.
- SeaBridge Investment Advisors's abrdn Life Sciences Investors position peaked at $27K in Q2 2015.
- 66 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2020.
Based on SeaBridge Investment Advisors's 13F filing for Q4 2020, filed 9 Feb 2021.